中文 | English
Return
Total: 129 , 1/13
Show Home Prev Next End page: GO
Author:( Xudong TANG)

1.The anti-tumor mechanism of (-)-epigallocatechin-3-gallate

Li HE ; Xudong TANG

Journal of International Oncology 2012;39(4):255-259

2.Research on Relationship between Expression of ??T Cell Subsets and TCM Syndrome Differentiation Type in Aplastic Anemia Patients

Xudong TANG ; Rouliu MA

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(10):-

3.Anti-tumor mechanisms of plant alkaloids

Xiaowei FENG ; Xudong TANG

Journal of International Oncology 2014;41(4):254-258

4.Discussion on Chinese medicine in treating post-infectious irritable bowel syndrome

Jianqin YANG ; Xudong TANG

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(04):-

5.New progress of myelodysplastic syndromes in the 55th ASH annual meeting

Xudong TANG ; Feng LIU

Journal of Leukemia & Lymphoma 2014;23(1):20-21,29

6.New progress of allogeneic transplantation in myelodysplastic syndromes in the 55th ASH annual meeting

Xudong TANG ; Feng LIU

Journal of Leukemia & Lymphoma 2014;23(2):73-74,78

7.Research progress of ghrelin on the functional dyspepsia

Lin Lü ; Suiping HUANG ; Xudong TANG

Journal of Medical Postgraduates 2014;(7):755-759

8.Clinical effect and life quality study of Shenyi capsule combined with docetaxel and cisplatin in treatment of advanced breast cancer

Xuliang ZHANG ; Xudong WANG ; Dongxin TANG

Chinese Journal of Biochemical Pharmaceutics 2015;(11):97-99

9.Iron homeostasis and diagnosis of hereditary iron overload: reports from the 56th American Society of Hematology annual meeting

Xudong TANG ; Lu ZHANG ; Feng LIU

Journal of Leukemia & Lymphoma 2015;24(1):46-49

10.Progress of guidelines for quantifying iron overload: reports from the 56th American Society of Hematology annual meeting

Xudong TANG ; Lu ZHANG ; Feng LIU

Journal of Leukemia & Lymphoma 2015;24(2):85-87

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 129 , 1/13 Show Home Prev Next End page: GO